Astrana Health Inc. Common Stock (ASTH) fair value

ACCE thesis

Astrana Health runs value-based primary care and population health contracts, taking on downside risk from health plans and Medicare Advantage programs and managing the cost of care for the members it serves. Revenue is growing 48.5%, which tells you the contract book is expanding quickly, but a 10.5% gross margin and 3.5% operating margin mean the economics are thin and depend heavily on medical cost ratios staying under control. The stock trades at 9.0 times forward earnings against 44.3 times trailing, a gap that signals the market expects a sharp swing from reported losses or minimal profit toward a much larger earnings base. The question for the deeper look is whether the forward estimates hold once medical costs are fully reflected in the numbers, since the spread between the two multiples leaves little room for a miss. The company is outside major indices, which may keep coverage and ownership thinner than the size would suggest.